RENASANT CORP (RNST)

US75970E1073 - Common Stock

35.38  +0.74 (+2.14%)

After market: 35.38 0 (0%)

Fundamental Rating

4

Overall RNST gets a fundamental rating of 4 out of 10. We evaluated RNST against 406 industry peers in the Banks industry. Both the profitability and financial health of RNST have multiple concerns. RNST is quite expensive at the moment. It does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year RNST was profitable.
RNST had a positive operating cash flow in the past year.
In the past 5 years RNST has always been profitable.
Each year in the past 5 years RNST had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 1.00%, RNST is in the better half of the industry, outperforming 69.55% of the companies in the same industry.
With a Return On Equity value of 6.73%, RNST is not doing good in the industry: 60.89% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 1%
ROE 6.73%
ROIC N/A
ROA(3y)0.95%
ROA(5y)0.93%
ROE(3y)7.34%
ROE(5y)6.77%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 25.73%, RNST is in the better half of the industry, outperforming 66.83% of the companies in the same industry.
RNST's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for RNST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 25.73%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y21.87%
PM growth 5Y-3.39%
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

RNST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RNST has more shares outstanding
Compared to 5 years ago, RNST has less shares outstanding
The debt/assets ratio for RNST has been reduced compared to a year ago.

2.2 Solvency

RNST has a debt to FCF ratio of 3.62. This is a good value and a sign of high solvency as RNST would need 3.62 years to pay back of all of its debts.
RNST has a Debt to FCF ratio of 3.62. This is comparable to the rest of the industry: RNST outperforms 45.30% of its industry peers.
RNST has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
RNST has a Debt to Equity ratio (0.17) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 3.62
Altman-Z N/A
ROIC/WACCN/A
WACC12.52%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

5

3. Growth

3.1 Past

The earnings per share for RNST have decreased strongly by -14.89% in the last year.
Measured over the past 5 years, RNST shows a small growth in Earnings Per Share. The EPS has been growing by 1.18% on average per year.
Looking at the last year, RNST shows a small growth in Revenue. The Revenue has grown by 5.75% in the last year.
RNST shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.19% yearly.
EPS 1Y (TTM)-14.89%
EPS 3Y20.86%
EPS 5Y1.18%
EPS Q2Q%-6.67%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y-1.53%
Revenue growth 5Y3.19%
Sales Q2Q%40.19%

3.2 Future

The Earnings Per Share is expected to grow by 3.47% on average over the next years.
RNST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.20% yearly.
EPS Next Y-14.62%
EPS Next 2Y-7.66%
EPS Next 3Y3.47%
EPS Next 5YN/A
Revenue Next Year-1.85%
Revenue Next 2Y15.9%
Revenue Next 3Y17.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.64, which indicates a correct valuation of RNST.
Compared to the rest of the industry, the Price/Earnings ratio of RNST is on the same level as its industry peers.
RNST is valuated cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.13, the valuation of RNST can be described as correct.
RNST's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, RNST is valued a bit cheaper.
Industry RankSector Rank
PE 12.64
Fwd PE 13.13

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, RNST is valued a bit more expensive than the industry average as 64.11% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 18.41
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)10.71
EPS Next 2Y-7.66%
EPS Next 3Y3.47%

6

5. Dividend

5.1 Amount

RNST has a Yearly Dividend Yield of 2.40%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.02, RNST has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.24, RNST has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.4%

5.2 History

The dividend of RNST has a limited annual growth rate of 2.12%.
RNST has paid a dividend for at least 10 years, which is a reliable track record.
RNST has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.12%
Div Incr Years0
Div Non Decr Years31

5.3 Sustainability

29.13% of the earnings are spent on dividend by RNST. This is a low number and sustainable payout ratio.
The dividend of RNST is growing, but earnings are growing more, so the dividend growth is sustainable.
DP29.13%
EPS Next 2Y-7.66%
EPS Next 3Y3.47%

RENASANT CORP

NYSE:RNST (12/20/2024, 8:04:01 PM)

After market: 35.38 0 (0%)

35.38

+0.74 (+2.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-22 2024-10-22/amc
Earnings (Next)01-21 2025-01-21/amc
Inst Owners88.07%
Inst Owner Change27.61%
Ins Owners4.58%
Ins Owner Change-0.2%
Market Cap2.25B
Analysts80
Price Target40.29 (13.88%)
Short Float %5.25%
Short Ratio7.56
Dividend
Industry RankSector Rank
Dividend Yield 2.4%
Dividend Growth(5Y)2.12%
DP29.13%
Div Incr Years0
Div Non Decr Years31
Ex-Date12-18 2024-12-18 (0.22)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.89%
Min EPS beat(2)2.61%
Max EPS beat(2)9.18%
EPS beat(4)4
Avg EPS beat(4)7.65%
Min EPS beat(4)1.89%
Max EPS beat(4)16.92%
EPS beat(8)6
Avg EPS beat(8)5.73%
EPS beat(12)9
Avg EPS beat(12)5.27%
EPS beat(16)12
Avg EPS beat(16)6.17%
Revenue beat(2)1
Avg Revenue beat(2)10.61%
Min Revenue beat(2)-3.28%
Max Revenue beat(2)24.5%
Revenue beat(4)1
Avg Revenue beat(4)2%
Min Revenue beat(4)-11.92%
Max Revenue beat(4)24.5%
Revenue beat(8)1
Avg Revenue beat(8)-2.4%
Revenue beat(12)3
Avg Revenue beat(12)-1.7%
Revenue beat(16)4
Avg Revenue beat(16)-1.34%
PT rev (1m)2.03%
PT rev (3m)0.55%
EPS NQ rev (1m)0.85%
EPS NQ rev (3m)-8.22%
EPS NY rev (1m)0.37%
EPS NY rev (3m)3%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)-1.06%
Revenue NY rev (1m)-1.93%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE 12.64
Fwd PE 13.13
P/S 3.24
P/FCF 18.41
P/OCF 16.32
P/B 0.85
P/tB 1.42
EV/EBITDA N/A
EPS(TTM)2.8
EY7.91%
EPS(NY)2.69
Fwd EY7.62%
FCF(TTM)1.92
FCFY5.43%
OCF(TTM)2.17
OCFY6.13%
SpS10.93
BVpS41.81
TBVpS24.89
PEG (NY)N/A
PEG (5Y)10.71
Profitability
Industry RankSector Rank
ROA 1%
ROE 6.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25.73%
GM N/A
FCFM 17.57%
ROA(3y)0.95%
ROA(5y)0.93%
ROE(3y)7.34%
ROE(5y)6.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y21.87%
PM growth 5Y-3.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 3.62
Debt/EBITDA N/A
Cap/Depr 48.41%
Cap/Sales 2.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 68.3%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC12.52%
ROIC/WACCN/A
Cap/Depr(3y)46.44%
Cap/Depr(5y)129.59%
Cap/Sales(3y)2.97%
Cap/Sales(5y)3.81%
Profit Quality(3y)164.62%
Profit Quality(5y)127%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.89%
EPS 3Y20.86%
EPS 5Y1.18%
EPS Q2Q%-6.67%
EPS Next Y-14.62%
EPS Next 2Y-7.66%
EPS Next 3Y3.47%
EPS Next 5YN/A
Revenue 1Y (TTM)5.75%
Revenue growth 3Y-1.53%
Revenue growth 5Y3.19%
Sales Q2Q%40.19%
Revenue Next Year-1.85%
Revenue Next 2Y15.9%
Revenue Next 3Y17.2%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.64%
FCF growth 3Y33.04%
FCF growth 5Y16.28%
OCF growth 1Y-73.28%
OCF growth 3Y21.81%
OCF growth 5Y12.59%